Exploring how social reward learning affects social pleasure in first-episode psychosis
Official title: Determining the Role of Social Reward Learning in Social Anhedonia in First-Episode Psychosis Using Motivational Interviewing in a Perturbation-Based Neuroimaging Approach
Run by University of Alabama at Birmingham · NCT05617898 · Data updated 2026-11-12
This study is testing whether different types of support can help young adults who have just experienced their first episode of psychosis feel more pleasure from social interactions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 35 Years |
| Sex | All |
| Enrollment | 152 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 2 sites (Birmingham, Alabama and 1 other locations) |
| Status | Recruiting |
| Started | June 14, 2023 |
| Main results expected | November 2027 |
| Study ends | November 2027 |
| Registry record updated | July 27, 2026 |
| Trial ID | NCT05617898 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 18-35 who have experienced their first episode of psychosis within the last three years and are currently on second-generation antipsychotic medications.
✕Probably not a fit
Patients with substance-induced psychosis or significant substance use disorders in the past three months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the connection between reduced sensitivity to social rewards and social anhedonia in individuals who have recently experienced their first episode of psychosis. Participants aged 18-35 will be randomized to receive either motivational interviewing or a control intervention, with their responses measured through social reward learning tasks performed in an fMRI scanner. The study aims to assess both behavioral and neural correlates of social reward sensitivity and subjective social pleasure. By understanding these relationships, the trial seeks to inform potential therapeutic approaches for enhancing social functioning in this population.
Why it matters
Potential benefit: If successful, this study could lead to improved interventions for enhancing social engagement and pleasure in individuals with psychosis.
How similar studies have gone: While the specific approach of this study may be novel, similar studies have shown promise in understanding the role of social rewards in mental health conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-35 years * A first episode of a psychotic illness that began within the past three years * Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 diagnosis of schizophrenia, schizophreniform, or schizoaffective disorder * Taking 2nd generation antipsychotic medications * Estimated premorbid IQ not less than 70 as assessed with the Wechsler Test of Adult Reading * Appropriate for scanning (i.e., no pacemaker or metal implants) and expressed willingness to participate in scanning * Sufficient fluency in English to comprehend testing procedures * Corrected vision of at least 20/30 Exclusion Criteria: * No evidence that substance use makes the diagnosis ambiguous (rule out substance-induced psychosis) * No evidence of moderate or severe alcohol or substance use disorder in the past 3 months * No clinically significant disease based on medical history (e.g., epilepsy) or significant head injury * For females: no current pregnancy * No sedatives or anxiolytics on the day of assessment * No medication change 3 weeks prior to enrollment
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting -
University of California Los Angeles
Los Angeles, California, United States Recruiting
Study contacts
- Study coordinator: Junghee Lee, PhD
- Email: jungheelee@uabmc.edu
- Phone: 205-934-8205
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Examining the effects of combined therapy for schizophrenia
This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.
-
State Representation in Early Psychosis 2
This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Combined brain stimulation and yoga for improving cognition in psychosis
This study tests whether active brain stimulation plus yoga can improve thinking skills and daily function in adults with psychosis.
-
See if an early-detection program reduces time to treatment for first-episode psychosis
We test whether a large, region-wide early-detection program can shorten the time from first psychotic symptoms to treatment and help people function better later.
-
Cerebellar imaging markers to predict antipsychotic response in first-episode psychosis
This will test whether cerebellar brain scans can predict how people with first-episode psychosis respond to 12 weeks of treatment with risperidone or aripiprazole.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.